Capital Fund Management (CFM)’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21,500
Closed -$3.69M 2116
2024
Q1
$3.69M Sell
21,500
-83,600
-80% -$15.6M 0.01% 1186
2023
Q4
$22.8M Buy
105,100
+64,600
+160% +$11.1M 0.06% 411
2023
Q3
$6.46M Buy
+40,500
New +$9.07M 0.02% 807
2020
Q1
Sell
-15,700
Closed -$2.69M 1926
2019
Q4
$2.69M Buy
+15,700
New +$2.62M 0.02% 748
2018
Q4
Sell
-3,100
Closed -$328K 2148
2018
Q3
$328K Buy
+3,100
New +$290K ﹤0.01% 1734

Other funds holding PODD

Capital Fund Management (CFM)'s PODD Position: Q1 2026 in Review

Capital Fund Management (CFM) increased its Insulet (PODD) stake by 6.3% in Q1 2026, buying an estimated $445K and bringing the position to 29,770 shares worth $6.25M. The position accounts for 0.03% of the portfolio, ranked #784.

Capital Fund Management (CFM) first reported a position in PODD in Q4 2013 and has held it in 16 quarters since. The position peaked at $23.4M in Q1 2024. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Capital Fund Management (CFM) held 29,770 shares of Insulet worth $6.25M as of Q1 2026.
  • Capital Fund Management (CFM) bought 1,769 Insulet shares in Q1 2026, an estimated $445K.
  • Insulet made up 0.03% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #784 holding.
  • Capital Fund Management (CFM) first reported a position in Insulet in Q4 2013 and has held it in 16 quarters since.
  • Capital Fund Management (CFM)'s Insulet position peaked at $23.4M in Q1 2024.
  • 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.